13F Portfolios

Avidity Partners Management LP: REPLIGEN CORP (RGEN): Quarterly 13F Position History

As of Q1 2026, Avidity Partners Management LP reported 77,800 shares of REPLIGEN CORP (RGEN), worth $9.2M and representing 2.1% of its 13F equity book. Quarter-over-quarter share count change: + 27,500 (+54.7%) . The position first appeared in Q2 2025 and has been disclosed across 4 13F-HR filings in Pactolio's tracked window.

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 4 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q1 2026 77,800 +27,500 +54.7% $9.2M 2.1% $118.3
Q4 2025 50,300 +27,000 +115.9% $8.2M 2.4% $163.9
Q3 2025 23,300 83,200 -78.1% $3.1M 0.7% $133.7
Q2 2025 106,500 $13.2M 2.7% $124.4

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.

When did Avidity Partners Management LP first disclose a RGEN position in 13F-HR filings?

Avidity Partners Management LP first reported REPLIGEN CORP (RGEN) on its 13F-HR filing for the period ending 2025-06-30 (Q2 2025). The position has appeared on 4 reported quarters within Pactolio's tracked window.

What was Avidity Partners Management LP's most recent quarter-over-quarter share-count change in RGEN?

Between Q4 2025 and Q1 2026, Avidity Partners Management LP added 27,500 shares of RGEN (+54.7%), bringing the total reported position to 77,800 shares at a market value of $9.2M.

Does the implied price-per-share represent Avidity Partners Management LP's cost basis in RGEN?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.